Skip to main content

Table 3 Medical costs, length of stay and clinical outcome of patients with eosinophilic bronchiectasis or non-eosinophilic bronchiectasis after propensity score matching

From: Eosinophilic bronchiectasis increases length and cost of hospitalization: a retrospective analysis in a hospital of southern China from 2012 to 2020

 

Cost in RMB, Median (Range)

 

Non-Eos

Eos

 

(n = 156)

(n = 156)

P-vaule

Total cost

9109 [6402, 12287]

15011 [9753, 27404]

< 0.0001*

 Medicine

2187 [1059, 3650]

5327 [2811, 9509]

< 0.0001*

   Antibacterial

793 [434, 2271]

1995 [757, 4340]

< 0.0001*

Length of hospital stay

5.0 [4.0, 6.0]

9.0 [6.0, 12.5]

< 0.0001*

Admission to ICU, n (%)

0 (0)

2 (1.3)

0.156

Respiratory failure, n (%)

7 (4.5)

11 (7.1)

0.331

Mortality, n (%)

0 (0)

0 (0)

 
  1. Abbreviations: ICU  intensive care unit, Eos eosinophilic bronchiectasis, Non-Eos non-eosinophilic bronchiectasis 
  2. *Statistically significant (P < 0.05)
Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us